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The beneficial versus detrimental effects of emergency 
coronary angioplasty for achieving myocardial reperfusion 
remain controversial. We studied 83 consecutive patients 
treated with angioplasty of occluded (Thrombolysis in 
Myocardial Infarction trial [TIMI] grade 0 or 1 flow) 
infarct-related arteries. Seventy patients had unsuccessful 
intravenous thrombolytic therapy and subsequently had 
rescue angioplasty and 13 patients had direct angioplasty 
without prior thrombolytic therapy. Forty-six patients had 
occlusion of the right coronary artery and 37 of the left 
anterior descending coronary artery. These two patient 
groups were similar with respect to age, percent of men, 
history of prior myocardial infarction, known cardiac risk 
factors and elapsed time from onset of chest pain to 
reperfusion. Angioplasty was initially successful in achiev- 
ing TIM1 grade 2 or 3 flow in 87% of right coronary artery 
occlusions and 92% of left anterior descending artery 
occlusions (p = 0.47). At 1 week follow-up catheterization, 
vessel patency was 63% for right coronary and 85% for left 
anterior descending infarct-related arteries (p = 0.03). 
Patients with right coronary artery occlusion had a higher 
The role of emergency percutaneous transluminal coronary 
angioplasty after thrombolytic therapy for acute myocardial 
infarction remains a subject of intense clinical research and 
controversy (1,2). Emergency angioplasty of the infarct- 
related artery has been demonstrated to decrease the resid- 
ual stenosis after successful thrombolysis (3,4), reduce the 
frequency of recurrent ischemic episodes during the early 
postinfarction period (5), improve global left ventricular 
ejection fraction (4,6,7) and restore vessel patency in the 
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incidence of life-threatening complications during angio- 
plasty than did patients with left anterior descending artery 
occlusion (p = 0.002) including, respectively: 1) the need 
for cardiopulmonary resuscitation in 16% versus 0% (p = 
0.02), 2) sustained ventricular tachycardia or ventricular 
fibrillation requiring electric cardioversion in 9% versus 
3% (p = 0.33), and 3) sustained hypotension requiring 
inotropic agents or balloon pump therapy in 11% versus 
3% (p = 0.16). The in-hospital mortality rate was 13% in 
patients with right versus 3% in patients with left anterior 
descending artery occlusion (p = 0.09), and hypoxic brain 
damage was seen in 4% in those with right versus 0% in 
those with left anterior descending artery occlusion (p = 
0.20). The mechanisms of the high complication rate in 
patients with acute right coronary artery angioplasty may 
involve the Bezold-Jarisch reflex or distal embolization of 
thrombus. These findings suggest that particular caution 
needs to be exercised when applying mechanical reperfu- 
sion strategies to patients with acute right coronary artery 
occlusion. 
(J Am Co11 Cardiol1989;14:1202-9) 
majority of patients with occluded arteries after failed throm- 
bolysis (4,6,8). Randomized trials (5,9,10) comparing imme- 
diate and delayed angioplasty (day 3 to 7 after infarction) 
have concluded, however, that the strategy of immediate 
angioplasty has no advantage in terms of left ventricular 
function and results in an increased incidence of bleeding 
complications and emergency coronary artery bypass graft- 
ing (5,9,10). Ongoing studies will address the usefulness of 
rescue angioplasty in the subgroup of patients who have an 
occluded artery 90 min after thrombolytic therapy. This 
subgroup, representing up to 50% of patients treated with 
intravenous streptokinase and up to 25% of patients treated 
with intravenous tissue-type plasminogen activator (5,7), 
would be the most likely group of patients to benefit from 
emergency mechanical recanalization of the infarct-related 
artery. 
After having observed several index cases of a rapid, 
profound clinical deterioration of previously stable patients 
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at the time of angioplasty of an occluded infarct-related 
artery, we prospectively studied all patients treated at our 
institution with rescue angioplasty for failed thrombolytic 
therapy or primary (direct) angioplasty. The purpose of this 
study was to fully characterize the clinical and angiographic 
follow-up data in patients undergoing emergency angioplasty 
of an acutely occluded coronary artery. 
Methods 
Study patients. The study group included all patients 
enrolled into prospective controlled trials of intravenous 
thrombolytic agents and coronary angioplasty for acute 
myocardial infarction at the University of Michigan Medical 
Center between September 1985 and March 1988. Inclusion 
criteria were the following: 1) chest pain >20 min but <6 h 
in duration unresponsive to sublingual nitroglycerin, and 2) 
electrocardiographic (ECG) ST segment elevation > 1 mm in 
two contiguous leads. Patients were excluded for the follow- 
ing reasons: 1) age >75 years; 2) cardiogenic shock; 3) 
history of recent stroke, surgery or trauma; 4) predisposition 
to bleeding; 5) previous Q wave infarction in the distribution 
of the infarct-related artery; and 6) inability to obtain in- 
formed consent. All patients who were found to have no 
perfusion (Thrombolysis in Myocardial Infarction trial 
[TIMI] grade 0 or 1) of the infarct-related artery at the 90 min 
angiogram (1 l), were not in Killip class IV and subsequently 
underwent emergency angioplasty of the infarct-related ar- 
tery were entered into the study. 
Study protocol. After informed consent was obtained, 
intravenous thrombolytic therapy was administered. De- 
pending on the thrombolytic protocol, the patient received 
either 1) tissue-type plasminogen activator (rt-PA), 100 to 
150 mg over 3 to 8 h; 2) rt-PA and urokinase at varying doses 
over 60 min; 3) streptokinase (1.5 million U) over 60 min; 4) 
placebo; or 5) no thrombolytic therapy. Vascular access was 
obtained through the femoral artery with the Seldinger 
technique, and 5,000 U of heparin was administered. The 
suspected infarct-related artery was studied first, and subse- 
quent angiography of the contralateral coronary artery and 
ventriculography were performed. If the angiogram obtained 
at 90 min after thrombolytic therapy showed TIM1 grade 0 or 
1 flow and the patient was judged to have suitable coronary 
anatomy, an additional 5,000 U of heparin was administered 
and angioplasty was attempted. Coronary angioplasty was 
performed only in the infarct-related artery, but if multiple 
lesions were present in that vessel, all were approached. 
After angioplasty, all patients were admitted to the coro- 
nary care unit, where they received intravenous heparin for 
at least 24 h to keep the partial thromboplastin time 1.5 to 2.0 
times the control value, aspirin (325 mg/day), diltiazem (30 to 
60 mg four times a day) and intravenous lidocaine for the first 
24 h. Beta-adrenergic blocking agents were not used unless 
specifically required to treat hypertension, arrhythmias or 
a 348 Enrolled 
Circumflex 
Figure 1. Selection of patients. The numbers in the circles represent 
the number of patients in each group. Twenty-four percent of 
patients (n = 118) enrolled in randomized studies of thrombolytic 
agents and angioplasty in acute myocardial infarction had no perfu- 
sion of the infarct-related artery on the 90 min angiogram and 
subsequently underwent angioplasty. LAD = left anterior descend- 
ing artery; PTCA = percutaneous transluminal coronary angio- 
plasty; RCA = right coronary artery: TIMI = Thrombolysis in 
Myocardial Infarction trial. 
postinfarction ischemia. Recurrent ischemia was aggres- 
sively treated with repeat angiography and angioplasty or 
coronary artery bypass grafting. Repeat cardiac catheteriza- 
tion to assess infarct-related vessel patency was systemati- 
cally done 7 to 10 days after infarction in all patients who 
gave consent. 
Major complications of angioplasty, defined as new 
events not present before angioplasty, were 1) death; 2) 
cardiac arrest, defined as hemodynamic compromise requir- 
ing el min of cardiopulmonary resuscitation; 3) sustained 
ventricular tachycardia or fibrillation lasting 30 s or requiring 
cardioversion; and 4) sustained hypotension, defined as 
systolic blood pressure <SO mm Hg, requiring inotropic 
support or intraaortic balloon pump therapy. Cineangio- 
graphic films were reviewed by a single independent ob- 
server in the angiographic core laboratory to verify initial 
infarct-related vessel TIM1 grade and that at the end of acute 
and 7 day catheterizations. 
Statistical analysis. Values are expressed as a mean val- 
ues +-1 SD unless otherwise specified. The comparison of 
the right coronary artery and left anterior descending artery 
complications, group demographics and infarct-related ar- 
tery patency rates were made by chi-square analysis or the 
Fisher exact test. 
Results 
During the study period, 348 patients were enrolled in 
prospective randomized studies of thrombolytic therapy and 
emergency angioplasty. Figure 1 shows the classification of 
patients by TIM1 grade and infarct-related vessel. The 83 
patients included in the present study represent all the 
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Table 1. Baseline Characteristics of 74 Patients With an Occluded 
Infarct-Related Artery Undergoing Angioplasty 
Characteristic* 
Age (yr) 
Gender (% male) 
Previous infarct (%) 
Smoking history (%) 
Diabetes mellitus (%) 
Hypertension (%) 
Hypercholesterolemia (%) 
Time from chest pain to 
vessel opened (h) 
RCA LAD 
(n = 37) (n = 37) 
54.0 * 9.5 53.9 f 10.6 
91 81 
9 14 
63 73 
11 8 
39 38 
26 18 
5.2 5.0 
Pacemaker pre-PICA (%) 
VTiVF pre-PTCA (%) 
IABP or pressors 
pre-PICA (%) 
4 0 
6 14 
6 16 
CPR pre-PTCA (%) 
Killip class pre-PICA (%) 
2 2 
I 
II 
III 
One vessel disease (%) 
Two vessel disease (%) 
Three vessel disease (%) 
Collateral vessels to 
infarct-related artery (%) 
86 77 
I1 20 
3 3 
58 74 
20 18 
22 8 
47 41 
*There were no significant differences (p < 0.05). CPR = cardiopulmo- 
nary resuscitation; IABP = intraaortic balloon pump; LAD = left anterior 
descending coronary artery; PTCA = percutaneous transluminal coronary 
angioplasty; RCA = right coronary artery; VTiVF = ventricular tachycardial 
ventricular fibrillation. 
patients with right coronary or left anterior descending 
artery occlusion who underwent emergency angioplasty. 
Seventy patients had unsuccessful thrombolytic therapy and 
13 had direct angioplasty after receiving placebo (6 patients) 
or no thrombolytic therapy (7 patients). There were 46 right 
coronary artery occlusions (27 proximal, 12 mid and 7 distal) 
and 37 left anterior descending occlusions (18 proximal, 17 
mid and 2 distal). Five patients had a circumflex coronary 
artery occlusion (1 proximal, 3 distal and 1 obtuse marginal). 
Of the 25 patients excluded for “other reasons” (Fig. l), 3 
developed cardiogenic shock before the angioplasty and 22 
did not undergo angioplasty because of left main disease or 
the equivalent (7 patients), emergency coronary artery by- 
pass grafting (5 patients), inability to cross the lesion with 
the guidewire (2 patients), demonstration that the infarct- 
related artery was a small branch (2 patients), catheteriza- 
tion laboratory equipment failure (1 patient), inability to 
determine the infarct-related artery (1 patient), death before 
catheterization (1 patient) and operator decision not to 
proceed with angioplasty (3 patients). 
Relevant demographic data and baseline characteristics 
of the study patients, grouped by infarct-related artery, are 
shown in Table 1. There were no significant differences in 
Percent MI 
TM 2 or 
3 Flow 
40 
34137 40146 29/34 24/39 
(92%) (87%) (85%) (63%) 
Figure 2. Infarct-related artery patency (TIM1 grade 2 or 3) in 83 
patients with an initially occluded vessel treated with angioplasty. 
Abbreviations as in Figure 1. 
patient age, percent of men, history of prior myocardial 
infarction, cardiac risk factors or elapsed time from the onset 
of chest pain to reperfusion. There was a trend toward more 
life-threatening complications before angioplasty in patients 
with a left anterior descending infarct-related artery. There 
was also a trend toward a greater incidence of multivessel 
disease in the right coronary artery group (p = 0.19). 
Rescue angioplasty was successful in opening occluded 
vessels to TIM1 grade 2 or 3 flow in 34 (92%) of 37 patients 
with a left anterior descending artery occlusion compared 
with 40 (87%) of 46 patients with a right coronary artery 
occlusion (p = 0.47), for an overall success rate of 89% 
(Fig. 2). Follow-up catheterization was performed in 87% 
of the patients. Of those not undergoing repeat catheter- 
ization, seven patients had died (two after emergency 
coronary bypass grafting), two patients had successful 
coronary artery bypass grafting and five patients refused 
follow-up catheterization. At 7 to 10 day follow-up study, 
the infarct-related vessel was patent in 29 (85%) of 34 
patients with a left anterior descending artery occlusion 
and 24 (63%) of 38 patients with a right coronary artery 
Table 2. Summary of Acute and In-Hospital Complications 
Occurring in 83 Patients With an Occluded Infarct-Related Artery 
Undergoing Angioplasty 
RCA LAD 
(n = 46) (n = 37) p Value 
Death in catheterization 
laboratory 
Cardiac arrest requiring CPR 
Sustained VT/VF 
Sustained hypotension 
In-hospital mortality rate 
Hypoxic brain damage 
0 
7 (16%) 
3 (9%) 
4 (11%) 
6 (13%) 
2 (4%) 
0 - 
0 0.02 
1 (3%) 0.33 
I (3%) 0.16 
1 (3%) 0.09 
0 0.20 
Abbreviations as in Table 1. 
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Table 3. Summary of 17 Patients With an Acute Complication During Angioplasty of an Occluded Infarct-Related Artery 
No. 
Pt. 
Age/ 
Gender 
Infarct-Related 
Artery 
Lytic 
Therapy 
Hours CP to 
Angioplasty Pre-Cath Status 
Hospital Outcome Events 
During PTCA 
Follow-Up 
Catheterization 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
69/M 
39/F 
34/M 
55/M 
54/F 
52/M 
72lM 
64/M 
51/M 
67lM 
72lF 
40/M 
55lM 
66/M 
50/M 
56/M 
58/M 
RCA prox 
LAD prox 
RCA prox 
RCA prox 
RCA prox 
RCA prox 
RCA prox 
LAD prox 
RCA mid 
RCA prox 
RCA prox 
RCA prox 
RCA mid 
RCA prox 
RCA prox 
RCA prox 
RCA prox 
IC SK 
rt-PA 
rt-PA 
rt-PA 
rt-PA 
rt-PA 
rt-PA 
rt-PA/UK 
rt-PA/UK 
rt-PA/UK 
rt-PA 
rt-PA 
rt-PA 
None 
rt-PA 
rt-PA 
None 
3.0 
4.3 
5.6 
5.0 
6.5 
5.2 
5.2 
4.3 
5.5 
4.5 
6.7 
5.5 
9.5 
3.5 
5.4 
2.9 
I.5 
Kiilip III, SBP 148. 
recurrent VT 
Killip I, SBP 115. VF 
Killip I. SBP 110 
Killip I, SBP 110 
Killip I, SBP 133 
Killip I, SBP 1 IO 
Killip 1, SBP 113 
Killip II. SBP 110 
Killip III, SBP I30 
Killip 1, SBP I18 
Killip I, SBP 132 
Killip 111, SBP 128. 
VTiVF requiring 
countershock 
Killip II, SBP I05 
Killip I, SBP 106 
Killip II, SBP 80 
Killip I, SBP 114, VI 
requiring lidocaine 
Killip I, SBP I IO 
Acute reocclusion, hypotension 
requiring IABP 
AIVR, hypotension requiring 
pressers 
VF when vessel opened 
Bradycardia and hypotension 
unresponsive to pacemaker, 
IABP and pressers 
Sustained hypotension requiring 
IABP, emergency CABG 
Asystole with reperfusion using 
guidewire, CPR required 
VF with reperfusion, CPR 
required 
VF with reperfusion 
RCA intermittently open, 
prolonged CPR for refractory 
VTiVF 
VF, then prolonged asystole 
requiring CPR 
VF, repeated shocks, CPR 
required 
VT/VF. asysstole, prolonged 
CPR 
Hypotension requiring pressers 
Recurrent VTNF and asystole, 
vessel opened and closed. 
prolonged CPR 
Polymorphic VT 
RCA intermittently open, VT 
and sustained hypotension 
requiring IABP 
VF 
Died 2 h later in CCU, 
no autopsy 
Ventricular arrhythmias, 
LAD TIM1 3 
Uncomplicated. 
occluded RCA 
Died 5 h later in CCU, 
autopsy showed no 
RV infarct 
Died day 3, no autopsy 
Uncomplicated, RCA 
TIM1 3 
RCA occluded, elective 
CABG 
Uncomplicated; LAD, 
TIM1 3 
No neurologic recovery, 
no repeat 
catheterization 
Gl bleeding, hut no 
recurrent ischemia. 
RCA TIM1 3 
CABG day 12. died day 
II4 
Anoxic brain damage, 
died day I7 
Uncomplicated, RCA 
TIM1 3 
Emergency CABG, died 
in operating room 
Uncomplicated, RCA 
TIM1 3 
Sepsis, refused repeat 
catheterization 
Uncomplicated, no 
repeat catheterizaiton 
AIVR = accelerated idioventricular rhythm; CABG = coronary artery bypass grafting; Cath = cardiac catheterization; CCU = coronary care unit; F = 
female; CP = chest pain; GI = gastrointestinal; IC SK = intracoronary streptokinase; M = male; prox = proximal; rt-PA = recombinant tissue-type plasminogen 
activator; SBP = systolic blood pressure (mm Hg); TIM1 = Thrombolysis in Myocardial Infarction trial: UK = urokinase: other abbreviations as in Table 1. 
occlusion (p = 0.03), for an overall 1 week patency rate of 
74% (Fig. 2). 
Acute life-threatening complications occurred during 
the angioplasty procedure in 33% of patients with a right 
coronary artery occlusion compared with only 5% of pa- 
tients with a left anterior descending occlusion (p = 0.002, 
Tables 2 and 3). At the time of angioplasty, patients with a 
right coronary artery occlusion had a higher incidence of 
refractory bradyarrhythmias, hypotension and ventricular 
tachyarrhythmias. Among patients with a right coronary 
artery occlusion, complications were more frequent in pa- 
tients with a proximal than in those with a mid (12 of 27 
proximal versus 2 of 12 mid, p = 0.06) or in those with 
a distal occlusion (12 of 27 proximal versus 0 of 7 distal, 
(p = 0.02). The in-hospital mortality rate tended to be 
higher in the right coronary artery group than in the left 
anterior descending artery group (13% versus l%, p = 0.09), 
as was the incidence of hypoxic brain damage (4% versus 
O%, p = 0.20) although these differences were not statis- 
tically significant. The clinical outcome of the five pa- 
tients with a circumflex artery occlusion is summarized in 
Table 4. 
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Table 4. Summary of Five Patients With Occluded Circumflex Vessel Undergoing Emergency Angioplasty 
Hours From 
Pt. Infarct-Related Lytic Chest Pain to Events During Hospital Outcome: Follow-Up 
No. Age/Gender Artery Therapy Angioplasty Angioplasty Catheterization 
1 65/M Obtuse marginal rt-PA 5.7 None Uncomplicated, TIM1 3 
2 53/M Distal None - None Uncomplicated, TIM1 3 
3 65/F Proximal rt-PA 5.9 None Uncomplicated, patient refused 
repeat catheterization 
4 60/M Distal rt-PA 5.6 Hypotension, bradycardia Uncomplicated, CABG day I2 
requiring atropine and 
pressors 
5 SZIF Distal rt-PA 5.0 None Lower GI bleed, repeat 
catheterization postponed 
6 73iF Proximal SK 6.1 None CABG day 2 for recurrent 
chest pain 
Abbreviations as in Tables I and 3. 
Discussion 
The benefits of thrombolytic therapy in acute myocardial 
infarction have been firmly established. Left ventricular 
function and survival, both in-hospital and at 1 year, are 
enhanced by early thrombolysis (12-17). Unfortunately, 
with currently available thrombolytic agents, up to 50% of 
patients treated with intravenous streptokinase and 25% 
treated with intravenous rt-PA will not achieve early reper- 
fusion of the infarct-related artery (5,11,15,18). Animal stud- 
ies (19,20) have clearly demonstrated that it is the early 
vessel patency that accounts for myocardial salvage. There- 
fore, a strategy of mechanical reperfusion with angioplasty 
for patients with failed thrombolysis has been proposed for 
clinical benefit (5). Several recent studies (5,9,10) have 
demonstrated no benefit of immediate versus delayed (day 3 
to 7) angioplasty after thrombolytic therapy. However, these 
studies did not limit the use of angioplasty to occluded 
arteries, but also applied emergency angioplasty to many 
arteries that had achieved adequate reperfusion by pharma- 
cologic means. Ongoing trials will directly address the clin- 
ical benefit of rescue angioplasty after failed thrombolytic 
therapy. 
We have demonstrated that angioplasty after failed 
thrombolytic therapy for acute myocardial infarction is 
successful in reestablishing perfusion of occluded vessels. 
Our 86% infarct-related artery patency rate after angioplasty 
compares favorably with the 80% to 95% patency rates 
published in other studies (4,6,8,21). Most of those other 
studies used angioplasty on subtotally occluded as well as 
occluded vessels, which may explain some of the higher 
initial patency rates. We found the infarct-related artery to 
be patent at 7 to 10 day follow-up catheterization in 74% of 
our patients, but there was more sustained patency of the left 
anterior descending than of the right coronary artery (85% 
versus 63%, p = 0.03). This finding is consistent with 
previously published (4,21-24) rates of early reocclusion in 
infarct-related arteries treated with acute angioplasty, but 
highlights the problems with sustained patency of the right 
coronary artery. The number of patients we studied with left 
circumflex artery occlusion (Table 4) was too small for 
statistical comparison. 
Our data show an alarmingly high incidence of life- 
threatening complications during emergency angioplasty 
when the occluded artery was the right coronary artery. 
Most previous studies (6,21) of thrombolytic therapy and 
angioplasty in acute myocardial infarction only briefly men- 
tioned intraprocedural complications. In the series reported 
by Stack et al. (25), there was a 30% major complication 
rate. Although those investigators did not classify their 
complications for right versus left coronary artery dilation, 
they reported incidence rates of 12% for ventricular tachy- 
cardia or fibrillation, 4% for cardiac or respiratory arrest and 
10% for asystole or severe bradycardia during emergency 
coronary angioplasty. 
The majority of our patients who developed complica- 
tions during angioplasty had initially clinically stable, Killip 
class I inferior myocardial infarction. At the 90 min angio- 
gram, 15 of the 17 patients who developed life-threatening 
complications had an occluded right coronary artery, and 2 
had a left anterior descending artery occlusion. After reper- 
fusion accomplished with the guidewire or angioplasty bal- 
loon, these patients had a dramatic worsening of their 
hemodynamic status. Eleven patients initially had ventricu- 
lar fibrillation, but only five of them responded promptly to 
electric countershock and the other six required prolonged 
resuscitation for refractory ventricular fibrillation or subse- 
quent asystole and bradyarrhythmias. After angioplasty, six 
patients immediately developed asystole, severe bradycar- 
dia or sustained hypotension, or a combination of these 
signs. 
Although the mechanism for the higher complication rate 
in patients with right coronary artery angioplasty in this 
setting is unknown, it may involve the Bezold-Jarisch reflex. 
It has long been recognized that acute inferoposterior myo- 
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cardial infarction is associated with a high incidence of sinus 
bradycardia and hypotension, which are responsive to atro- 
pine (26,27). This region of the heart has an abundance of 
nonmyelinated vagal afferent fibers (28,29). These cardiac 
receptors are inhibitory and constitute the afferent limb of 
the Bezold-Jarisch reflex (30,31). On stimulation of these 
fibers, there is an increase in parasympathetic activity along 
with an inhibition of sympathetic activity, causing the brady- 
cardia and hypotension characteristic of the Bezold-Jarisch 
reflex (30). Thoren (32) recorded the activity of these fibers 
during temporary occlusion of the right coronary artery in 
cats and found an eightfold increase above baseline activity. 
After prolonged occlusion (up to 40 min), he observed a 
paradoxic sharp increase in receptor discharge on release of 
the occlusion (32). This sudden increase in vagal activity 
may be responsible for the Bezold-Jarisch reflex observed 
clinically on reperfusion. 
The Bezold-Jarisch reflex has been described in several 
clinical settings, such as during contrast injection of the 
coronary artery supplying the inferior left ventricular wall 
(33,34) and during coronary artery spasm and resultant 
ischemia of the inferior wall (35). Wei et al. (36) described 
transient hypotension and bradycardia accompanying reper- 
fusion by intracoronary thrombolytic agents given <3 h after 
the onset of an acute myocardial infarction. They noted a 
significantly greater decrease in blood pressure and heart 
rate on angiographically confirmed reperfusion of the right 
coronary compared with that of the left anterior descending 
artery (36). Koren et al. (37) described a similar phenomenon 
during the use of high dose intravenous streptokinase. There 
was clinical evidence of the Bezold-Jarisch reflex in 42% of 
the treated inferior myocardial infarctions but in only 7% of 
anterior infarctions. Their study, however, did not have 
acute angiographic demonstration of vessel patency at the 
time of the clinically manifest Bezold-Jarisch reflex. It is 
possible that the profound bradycardia and hypotension we 
witnessed, both as an initial event and after countershock of 
ventricular fibrillation, was due to the sudden nature of 
mechanical reperfusion as compared with intravenous 
thrombolytic therapy. 
Our findings of frequent ventricular arrhythmias at the 
time of angioplasty are corroborated in a randomized trial by 
Timmis et al. (38), who demonstrated more significant ar- 
rhythmias with direct angioplasty-mediated reperfusion than 
with intracoronary streptokinase (38). In the experimental 
model, the ventricular fibrillation threshold is markedly 
decreased during the first minute of sudden reperfusion, but 
then rapidly returns to baseline (39). The incidence of 
ventricular fibrillation is higher in experimental animals 
undergoing rapid reperfusion. Sewell et al. (40) found no 
correlation between ventricular fibrillation and the duration 
of coronary artery occlusion, but a strong correlation with 
rapidity of reperfusion. Petropoulous and Meijne (41) ob- 
served that dogs undergoing reperfusion at a high level of 
pressure had a 28.6% incidence of ventricular fibrillation, 
whereas no dog undergoing slow reperfusion at a low pres- 
sure developed ventricular fibrillation. The mechanism of 
rapid reperfusion-induced ventricular fibrillation is poorly 
understood, but may be due to rapid washout of metabolites 
(41-44). The use of antiarrhythmic drugs has not been shown 
to decrease the incidence of ventricular tachyarrhythmias on 
reperfusion (45). 
Other possible mechanisms for the acute deterioration 
seen during right coronary artery angioplasty include distal 
embolization of thrombus, bradycardia-mediated ventricular 
tachyarrhythmias and right ventricular myocardial infarc- 
tion The right coronary artery generally is a large tortuous 
vessel with a slower flow rate and is thus relatively predis- 
posed to more clot burden. Angioplasty in this setting may 
lead to distal microembolization of fibrin, resulting in a 
watershed zone of infarcted tissue and areas of myocardium 
that have been reperfused adjacent to areas that are still 
ischemic. These changes would set up the potential for 
ventricular reentrant circuits. 
Although tachycardia and increased catecholamines are 
most often associated with ventricular arrhythmias, brady- 
cardia in the setting of acute myocardial infarction has also 
been associated with malignant ventricular arrhythmias, 
both in experimental preparations (46,47) and clinically (48). 
Scherlag et al. (46) induced ventricular tachyarrhythmias by 
vagal stimulation in 22% of dogs with an acutely occluded 
left anterior descending artery. The proposed mechanism 
involves reentrant pathways set up by inhomogeneous re- 
covery of excitability of the myocardial fibers (46,49). In 
patients with Bezold-Jarisch-induced bradycardia, there 
may be enhanced disparity in refractoriness and, therefore, a 
predisposition to ventricular fibrillation. 
Acute right ventricular infarction can cause profound 
hypotension as a result of the sudden decrease in left 
ventricular preload. It is unlikely that abrupt opening of the 
right coronary artery with angioplasty causes incremental 
right ventricular myocardial infarction. Although many of 
the patients in the current study may have suffered from 
some right ventricular myonecrosis, hemodynamic monitor- 
ing of our patients did not suggest the development of a new 
or more extensive right ventricular infarction. Only one 
patient in our series who died early after angioplasty under- 
went autopsy and, in that case, there was no evidence of 
right ventricular infarction. 
These results point out that, if rescue or direct angio- 
plasty of the right coronary artery in the setting of acute 
myocardial infarction is considered, the procedure should be 
approached with increased caution. The placement of radi- 
olucent defibrillation patches on the patient’s chest before 
the procedure will allow for rapid and repeated electric 
cardioversion if ventricular arrhythmias occur. Although 
benefits from emergency right coronary angioplasty may 
subsequently be demonstrated for selected patients in ran- 
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domized clinical trials, awareness of the risks involved and 
further elucidation of the mechanism of clinical deterioration 
will be important. Because the hazard of emergency right 
coronary angioplasty is emphasized by our series of patients, 
it will be increasingly difficult to justify such intervention in 
patients with truly uncomplicated inferior wall myocardial 
infarction. 
We extend particular appreciation to Annette Gacioch, Sheree Wilson and 
Darrell Debowey for the preparation of the manuscript. 
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